Physician profile
Amy Scott
NPI 1750829040
$808.23
in general payments reported to CMS, 2019-2025
10 companies · $71.03 in 2025
The $71.03 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $375 · 2023: $85.54 · 2025: $71.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $543.75 | 2021-2023 | Wegovy |
| Reshape Lifesciences INC. | $108.47 | 2022 | |
| Smith+Nephew, INC. | $35.44 | 2025 | Collagenase Santyl, Renasys Touch, Pico 14 |
| Microport Orthopedics INC | $23.20 | 2022 | |
| Medtronic, INC. | $20.05 | 2025 | Venaseal |
| Boston Scientific Corporation | $17.83 | 2021 | |
| Tactile Systems Technology INC | $15.54 | 2025 | Flexitouch Plus, Nimbl |
| Lilly USA, LLC | $15.46 | 2022 | |
| Intra-Sana Laboratories | $14.35 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Pfizer INC. | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.